NCT07453719Not yet recruiting
Improving Medication Management in COPD
Feasibility Pilot Trial of a Pharmacist-led Medication Management Intervention for Multi-Morbid Adults With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
A pilot trial to examine feasibility of a pharmacist-led intervention for patients with COPD (Chronic Obstructive Pulmonary Disease) and multimorbidity to improve medication safety and reduce dyspnea. Patients will receive inhaler teaching and medication optimization counseling. Outcomes include feasibility, acceptability, appropriateness, and exploratory measures such as medication discontinuation and patient-reported symptom burden.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- First submitted
- 25 Feb 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 31 May 2027
- Lead sponsor
- Duke University
- Diseases
- COPD
- NCT number
- NCT07453719
What you commit to
- Study type: Interventional
- Planned participants: 92
- From 1 Oct 2026 to the primary completion date, 31 May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Opioid use disorder
- Cognitive impairment
Age
- Under age 18 (caregivers/clinicians)
- Under age 45 (patients)
Other
- Unable to communicate in English
Who the study is looking for
- Age ≥ 45
- Diagnosis of COPD
- Medicare/Medicaid insured
- Using an inhaler
- Reports dyspnea or suboptimal medication adherence
Age in the registry: 45 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.